Prostatic Hyperplasia

"Prostatic Hyperplasia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.

Descriptor ID	D011470
MeSH Number(s)	C12.294.565.500
Concept/Terms	Prostatic Hyperplasia Prostatic Hyperplasia Hyperplasia, Prostatic Prostatic Hypertrophy Prostatic Hypertrophy Adenoma, Prostatic Adenoma, Prostatic Adenomas, Prostatic Prostatic Adenomas Prostatic Adenoma Benign Prostatic Hyperplasia Benign Prostatic Hyperplasia Prostatic Hyperplasia, Benign Prostatic Hypertrophy, Benign Prostatic Hypertrophy, Benign Benign Prostatic Hypertrophy Hypertrophy, Benign Prostatic

Below are MeSH descriptors whose meaning is more general than "Prostatic Hyperplasia".

Diseases [C]
Male Urogenital Diseases [C12]
Genital Diseases, Male [C12.294]
Prostatic Diseases [C12.294.565]
Prostatic Hyperplasia [C12.294.565.500]

Below are MeSH descriptors whose meaning is related to "Prostatic Hyperplasia".

Below are MeSH descriptors whose meaning is more specific than "Prostatic Hyperplasia".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prostatic Hyperplasia" by people in this website by year, and whether "Prostatic Hyperplasia" was a major or minor topic of these publications.

Bar chart showing 25 publications over 13 distinct years, with a maximum of 5 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	0	1	1
2004	1	0	1
2006	1	2	3
2009	3	2	5
2010	1	0	1
2011	1	1	2
2014	1	2	3
2015	1	0	1
2016	2	2	4
2018	1	0	1
2019	1	0	1
2021	1	0	1
2024	1	0	1

Below are the most recent publications written about "Prostatic Hyperplasia" by people in Profiles.

White JA, Kaninjing ET, Adeniji KA, Jibrin P, Obafunwa JO, Ogo CN, Mohammed F, Popoola A, Fatiregun OA, Oluwole OP, Thorpe RJ, Karanam B, Elhussin I, Ambs S, Tang W, Davis M, Polak P, Campbell MJ, Brignole KR, Rotimi SO, Dean-Colomb W, Odedina FT, Yates C. Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. Prostate. 2024 Apr; 84(5):460-472.

View in: PubMed
Dang T, Liou GY. Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt. Sci Rep. 2018 05 16; 8(1):7718.

View in: PubMed
Murphy AB, Nyame YA, Batai K, Kalu R, Khan A, Gogana P, Dixon M, Macias V, Kajdacsy-Balla A, Hollowell CM, Catalona WJ, Kittles R. Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy? Prostate Cancer Prostatic Dis. 2017 03; 20(1):55-60.

View in: PubMed
Udensi UK, Tchounwou PB. Oxidative stress in prostate hyperplasia and carcinogenesis. J Exp Clin Cancer Res. 2016 09 08; 35(1):139.

View in: PubMed
Dai L, Li J, Xing M, Sanchez TW, Casiano CA, Zhang JY. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer. Prostate. 2016 11; 76(15):1375-86.

View in: PubMed
Li J, Dai L, Lei N, Xing M, Li P, Luo C, Casiano CA, Zhang JY. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget. 2016 Jul 12; 7(28):43546-43556.

View in: PubMed
Winchester D, Ricks-Santi L, Mason T, Abbas M, Copeland RL, Beyene D, Jingwi EY, Dunston GM, Kanaan YM. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients. Anticancer Res. 2015 Jul; 35(7):3811-9.

View in: PubMed
Gandhi SD, Patel SA, Maltenfort M, Anderson DG, Vaccaro AR, Albert TJ, Rihn JA. Patient and surgical factors associated with postoperative urinary retention after lumbar spine surgery. Spine (Phila Pa 1976). 2014 Oct 15; 39(22):1905-9.

View in: PubMed
Dai L, Li J, Ortega R, Qian W, Casiano CA, Zhang JY. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. J Immunol Res. 2014; 2014:827827.

View in: PubMed
Bhojani N, Gandaglia G, Sood A, Rai A, Pucheril D, Chang SL, Karakiewicz PI, Menon M, Olugbade K, Ruhotina N, Sammon JD, Sukumar S, Sun M, Ghani KR, Schmid M, Varda B, Kibel AS, Zorn KC, Trinh QD. Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program. J Endourol. 2014 Jul; 28(7):831-40.

View in: PubMed

People

Explore

Similar Concepts

Top Journals